Cybin (CYBN.NE) announced that their wholly-owned subsidiary, Adelia Therapeutics, has achieved certain earn-out milestones for the period commencing January 1, 2021. The terms of the milestone earnings were agreed…
Adelia Therapeutics
Cybin’s (CYBN.NE) subsidiary Adelia Therapeutics completed earnout milestones originally set in a contribution agreement for the period of January 1, 2021, following Cybin’s acquisition of Adelia. There are a…